At close: May 18 at 4:00:00 PM EDT ...
THOUSAND OAKS, Ca.--(BUSINESS WIRE)--Dyve Biosciences, Inc. today announced that it has received clearance from the U.S. Food and Drug Administration to proceed with a Phase 2 trial of DYV-700, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results